The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
Open accessAbstract
// Xiaodan Meng 1 , Volkmar Müller 2 , Karin Milde-Langosch 2 , Fabian Trillsch 2 , Klaus Pantel 1 , Heidi Schwarzenbach 1 1 Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany 2 Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany Correspondence to: Heidi Schwarzenbach, e-mail: hschwarz@uke.uni-hamburg.de Keywords: epithelial ovarian cancer, exosomal miRNAs, exosomes, diagnosis, prognosis Received: October 13, 2015 Accepted: January 29, 2016 Published: March 02, 2016 ABSTRACT Exosomes are membrane vesicles that mediate intercellular communication by transporting their molecular cargo from cell to cell. We investigated whether serum levels of exosomal miR-373, miR-200a, miR-200b and miR-200c and circulating exosomes have diagnostic and prognostic relevance in a cohort of 163 epithelial ovarian cancer (EOC) patients using TaqMan MicroRNA assays and ELISA. The serum concentrations of exosomal miR-373 ( p = 0.0001), miR-200a ( p = 0.0001), miR-200b ( p = 0.0001) and miR-200c ( p = 0.028) were significantly higher in EOC patients than healthy women. The levels of miR-200a ( p = 0.0001), miR-200b ( p = 0.0001) and miR-200c ( p = 0.019) could distinguish between malignant and benign ovarian tumors. While the levels of miR-373 and miR-200a were increased in all FIGO/lymph node stages ( p = 0.0001), the levels of miR-200b and miR-200c were higher in patients with FIGO stage III–IV ( p = 0.0001, p = 0.008, respectively) including lymph node metastasis ( p = 0.0001, p = 0.004, respectively) than FIGO stages I–II. The increased levels of miR-200b and miR-200c were also associated with CA125 values ( p = 0.0001, p = 0.0001, respectively) and a shorter overall survival ( p = 0.007, p = 0.017, respectively). The levels of exosomes were excessively elevated in EOC patients ( p = 0.0001). In all three cohorts, they were positively associated with the serum levels of exosomal miR-373 ( p = 0.004), miR-200a ( p = 0.0001), miR-200b ( p = 0.0001) and miR-200c ( p = 0.008). In conclusion, the increased levels of exosomal miR-200b and miR-200c mainly observed in advanced EOC suggest that these microRNAs may be involved in tumor progression. The high concentrations of exosomes in EOC patients imply an excessive, active exosomal secretion in EOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Self-citationPark, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
Zhang, J., Li, S., Li, L., Li, M., Guo, C., Yao, J., & Mi, S. (2015) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.02.001 · Cited by 1,901
Jayson, G. C., Kohn, E. C., Kitchener, H. C., & Ledermann, J. A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62146-7 · Cited by 1,850
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,705
du Bois, A., Reuss, A., Pujade‐Lauraine, E., Harter, P., Ray‐Coquard, I., & Pfisterer, J. (2009) · Cancer · doi:10.1002/cncr.24149 · Cited by 1,638
(2005) · doi:10.1093/nar/gki200 · Cited by 1,208
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Azmi, A. S., Bao, B., & Sarkar, F. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9441-9 · Cited by 1,167
Exosomes: proteomic insights and diagnostic potential
Simpson, R. J., Lim, J. W., Moritz, R. L., & Mathivanan, S. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.17 · Cited by 1,108
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., Egan, D. A., Li, A., Huang, G., Klein-Szanto, A. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1681 · Cited by 975
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 969
Self-citationThe ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Pant, S., Hilton, H., & Burczynski, M. E. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.037 · Cited by 473
Data Normalization Strategies for MicroRNA Quantification
Schwarzenbach, H., da Silva, A. M., Calin, G., & Pantel, K. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239459 · Cited by 468
Self-citationEichelser, C., Stückrath, I., Müller, V., Milde-Langosch, K., Wikman, H., Pantel, K., & Schwarzenbach, H. (2014) · Oncotarget · doi:10.18632/oncotarget.2520 · Cited by 376
Self-citationDavalos, V, Moutinho, C., Villanueva, A., Boque, R., Silva, P., Carneiro, F., & Esteller, M. (2012) · Oncogene · doi:10.1038/onc.2011.383 · Cited by 351
Humphries, B., & Yang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3052 · Cited by 346
Ostenfeld, M. S., Jeppesen, D. K., Laurberg, J. R., Boysen, A. T., Bramsen, J. B., Primdal-Bengtson, B., Hendrix, A., Lamy, P., Dagnaes-Hansen, F., Rasmussen, M. H., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3512 · Cited by 294
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Hu, X., Macdonald, D. M., Huettner, P. C., Feng, Z., El Naqa, I. M., Schwarz, J. K., Mutch, D. G., Grigsby, P. W., Powell, S. N., & Wang, X. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.022 · Cited by 275
Horizontal transfer of microRNAs: molecular mechanisms and clinical applications
Chen, X., Liang, H., Zhang, J., Zen, K., & Zhang, C.-Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2003-z · Cited by 257
Kobayashi, M., Salomon, C., Tapia, J., Illanes, S. E., Mitchell, M. D., & Rice, G. E. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-4 · Cited by 225
Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls
Hu, Z., Dong, J., Wang, L.-E., Ma, H., Liu, J., Zhao, Y., Tang, J., Chen, X., Dai, J., Wei, Q., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs030 · Cited by 215
Magdalena Derbis, M. S. (2012) · Gynecology & Obstetrics · doi:10.4172/2161-0932.s4-003 · Cited by 195
Kan, C. W., Hahn, M. A., Gard, G. B., Maidens, J., Huh, J. Y., Marsh, D. J., & Howell, V. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-627 · Cited by 182
Epithelial–Mesenchymal Transition in Ovarian Carcinoma
Davidson, B., Tropé, C. G., & Reich, R. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00033 · Cited by 173
Koutsaki, M., Spandidos, D. A., & Zaravinos, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.022 · Cited by 136
Zuberi, M., Mir, R., Das, J., Ahmad, I., Javid, J., Yadav, P., Masroor, M., Ahmad, S. T., Ray, P., & Saxena, A. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1303-1 · Cited by 133
Müller, V., Gade, S., Steinbach, B., Loibl, S., von Minckwitz, G., Untch, M., Schwedler, K., Lübbe, K., Schem, C., Fasching, P. A., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3079-3 · Cited by 123
Self-citationChen, D., Dang, B., Huang, J., Chen, M., Wu, D., Xu, M., Li, R., & Yan, G. (2015) · Oncotarget · doi:10.18632/oncotarget.4702 · Cited by 117
Diverse functions of miR-373 in cancer
Wei, F., Cao, C., Xu, X., & Wang, J. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0523-z · Cited by 110
NAKANO, H., Yamada, Y., Miyazawa, T., & Yoshida, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1896 · Cited by 109
The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer
Schwarzenbach, H. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1069183 · Cited by 92
Self-citationThe miR-200 Family: Versatile Players in Epithelial Ovarian Cancer
Muralidhar, G. G., & Barbolina, M. V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160816833 · Cited by 80
MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer
Zhang, Y., Zhao, F.-J., Chen, L.-L., Wang, L.-Q., Nephew, K. P., Wu, Y., & Zhang, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2577 · Cited by 75
The heterogeneity of ovarian cancer
Meinhold-Heerlein, I. M., & Hauptmann, S. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3114-3 · Cited by 71
S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours
Wagner, U. A. G., Harter, P., Hilpert, F., Mahner, S., Reuß, A., du Bois, A., Petru, E., Meier, W., Ortner, P. A., König, K., et al. (2013) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0033-1350713 · Cited by 43
MicroRNA Profiling of Exosomes Isolated from Biofluids and Conditioned Media
Rani, S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1062-5_12 · Cited by 13
Cited by
Mateescu, B., Kowal, E. J. K., van Balkom, B. W. M., Bartel, S., Bhattacharyya, S. N., Buzás, E. I., Buck, A. H., de Candia, P., Chow, F. W. N., Das, S., et al. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1286095 · Cited by 720
Extracellular vesicles in immunomodulation and tumor progression
Marar, C., Starich, B., & Wirtz, D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00899-0 · Cited by 584
The biology, function, and applications of exosomes in cancer
Liu, J., Ren, L., Li, S., Li, W., Zheng, X., Yang, Y., Fu, W., Yi, J., Wang, J., & Du, G. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.001 · Cited by 561
ncRNA-Encoded Peptides or Proteins and Cancer
Wang, J., Zhu, S., Meng, N., He, Y., Lu, R., & Yan, G.-R. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.001 · Cited by 330
Exosomes promote pre-metastatic niche formation in ovarian cancer
Feng, W., Dean, D. C., Hornicek, F. J., Shi, H., & Duan, Z. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1049-4 · Cited by 289
Metadata
- Authors
- Meng, X., Müller, V., Milde-Langosch, K., Trillsch, F., Pantel, K., & Schwarzenbach, H.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-03-02
- Volume
- 7
- Issue
- 13
- Pages
- 16923-16935
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2319374670
- Cited by
- 273
- References
- 46
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.